Tilray Brands Inc. (NASDAQ: TLRY) stock fell -2.48% on Thursday to $2.36 against a previous-day closing price of $2.42. With 12.29 million shares changed hands, the volume of the stock remained heavier than its average volume of 10.72 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $2.4200 whereas the lowest price it dropped to was $2.3200. The 52-week range on TLRY shows that it touched its highest point at $5.12 and its lowest point at $2.17 during that stretch. It currently has a 1-year price target of $3.34. Beta for the stock currently stands at 2.64.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TLRY was down-trending over the past week, with a drop of -3.28%, but this was up by 8.26% over a month. Three-month performance dropped to -16.31% while six-month performance fell -35.52%. The stock lost -44.60% in the past year, while it has lost -12.27% so far this year. A look at the trailing 12-month EPS for TLRY yields -3.07 with Next year EPS estimates of -0.18. For the next quarter, that number is -0.05. This implies an EPS growth rate of 27.30% for this year and 90.90% for next year. EPS is expected to grow by 37.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -63.40%.
Float and Shares Shorts:
At present, 615.53 million TLRY shares are outstanding with a float of 609.65 million shares on hand for trading. On May 14, 2023, short shares totaled 49.5 million, which was 8.01% higher than short shares on Apr 13, 2023. In addition to Mr. Irwin David Simon as the firm’s Pres, CEO & Chairman, Mr. Carl A. Merton CA, CBV, CPA serves as its CFO & Principal Accounting Officer.
Institutional Ownership:
Through their ownership of 11.70% of TLRY’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 5.08% of TLRY, in contrast to 4.88% held by mutual funds. Shares owned by individuals account for 11.73%. As the largest shareholder in TLRY with 1.23% of the stake, ETF Managers Group LLC holds 7,598,523 shares worth 7,598,523. A second-largest stockholder of TLRY, Susquehanna Financial Group LLLP, holds 3,475,316 shares, controlling over 0.56% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in TLRY, holding 2,982,062 shares or 0.48% stake. With a 1.25% stake in TLRY, the ETFMG Alternative Harvest ETF is the largest stakeholder. A total of 7,737,751 shares are owned by the mutual fund manager. The Horizons Marijuana Life Sciences, which owns about 0.52% of TLRY stock, is the second-largest Mutual Fund holder. It holds 3,215,184 shares valued at 7.56 million. Global X Cannabis ETF holds 0.43% of the stake in TLRY, owning 2,684,758 shares worth 6.31 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Feb 27, 2023, TLRY reported revenue of $153.32M and operating income of -$99.45M. The EBITDA in the recently reported quarter was $299.38M and diluted EPS was -$0.90.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TLRY since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With TLRY analysts setting a high price target of $5.00 and a low target of $2.25, the average target price over the next 12 months is $3.31. Based on these targets, TLRY could surge 111.86% to reach the target high and fall by -4.66% to reach the target low. Reaching the average price target will result in a growth of 40.25% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded TLRY stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 18 while that of sell transactions has risen to 24 over the past year. The total number of shares bought during that period was 694,833 while 2,109,398 shares were sold.
